Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Feb  | Jan

	Dr Reddy's Q2 revenues up 92% to Rs 4.7 billion fuelled by Fluoxetine; Special interim dividend of 100% declared October 31, 2001
	Dr Reddy's to release Qtr 2 results Oct 31, 2001; Earnings call slated for Nov 1, 2001 October 30, 2001
	Novo Nordisk continues development of DRF 2725 (NN622) without Novartis; Dr Reddy's-Novo Nordisk agreement remains unchanged October 29, 2001
	Dr Reddy's launches Livizi : a unique e-healthcare initiative October 20, 2001
	MRTPC dismisses case against Dr Reddy's October 18, 2001
	Dr Reddy's Laboratories receives USFDA final approval for Enalapril Maleate and HCTZ Tablets October 16, 2001
	Dr Reddy's receives DCGI approval for Grastim product insert October 1, 2001

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.